TMTP1-modified nanocarrier boosts cervical cancer immunotherapy by eliciting pyroptosis

Hanjie Xu & Ling Xi et al. · 2025-04-13

5Citations
TL;DR

The combination of GA and ICG therapy utilizing the constructed nanocarriers presents an attractive therapeutic strategy to trigger pyroptosis and potentiate PD-1 blockade therapy for cervical cancer chemo-immunotherapy.

AI-generated by Semantic Scholar

Authors
Hanjie Xu, Danya Zhang, Yu Zhang, Yuxin Chen, Yue Sun, Jie Li, Songwei Tan, Ying Zhou, Rui Wei, Fei Li, Ling Xi